HHealth Read More Daily tomatoes lowered a key marker of liver fat in MASLD trialAugust 3, 2026 A six-week tomato-rich diet outperformed a tomato-free diet on an important marker of hepatic steatosis, pointing to a…
HHealth Read More Study tests chronotype’s liver link and finds no significant associationJuly 21, 2026 A small Italian study tested whether an individual’s preferred daily schedule aligns with hidden liver changes, but found…
HHealth Read More Prickly pear may pack a surprising punch against metabolic syndromeApril 7, 2026 This new review explores how prickly pear fruit may act on oxidative stress, inflammation, insulin resistance, and lipid…
HHealth Read More EVA1A regulates fatty acid transporter CD36 in fatty liver diseaseMarch 10, 2026 Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD) is characterized by excessive accumulation of lipids in hepatocytes and is closely associated…
HHealth Read More How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?March 4, 2026 A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…
HHealth Read More New study identifies the optimal exercise dose for reducing hepatic steatosisJanuary 23, 2026 Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not only drives…
HHealth Read More Understanding leptin’s dual function in MAFLD pathogenesisNovember 15, 2025 Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a predominant chronic liver condition globally, intricately linked with…
HHealth Read More The vicious circle of aging and metabolic dysfunction-associated steatotic liver diseaseAugust 1, 2025 Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) and aging are locked in a vicious circle: senescence of…